Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1453002 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL131648 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL129429 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL130045 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL20503164 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL127964 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL1454994 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL1452859 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL1005861 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL131546 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112724088-A | Uracil compound and anti-tumor application thereof | 中国医学科学院医药生物技术研究所 | 2021-04-30 | — | — | CN | claimed |
| CN-112618550-A | Antineoplastic uracil compound and lipid composition thereof | 中国医学科学院医药生物技术研究所 | 2021-04-09 | — | — | CN | claimed |
| CN-107001532-B | Copolymer and aqueous coating composition using same | 株式会社ADEKA | 2020-11-20 | — | — | CN | claimed |
| EP-1459626-B1 | Sustained release dispenser comprising two or more sex pheromone substances and a pest control method | SHINETSU CHEMICAL CO (JP) | 2020-01-29 | — | — | EP | claimed |
| EP-3161026-B1 | PHOSPHONIC COPOLYMER AND USE THEREOF IN THE COSMETICS FIELD | OREAL (FR) | 2018-10-10 | — | — | EP | claimed |
| EP-2365950-B1 | PRODUCTION OF PHEROMONES AND FRAGRANCES FROM SUBSTITUTED AND UNSUBSTITUTED 1-ALKEN-3-YL ALKYLATES | BEDOUKIAN RES INC (US) | 2014-10-29 | — | — | EP | claimed |
| EP-1221836-B1 | NOVEL BISEXUAL ATTRACTANTS, AGGREGANTS AND ARRESTANTS FOR ADULTS AND LARVAE OF CODLING MOTH AND OTHER SPECIES OF LEPIDOPTERA | TRECE INC (US) | 2010-01-20 | — | — | EP | claimed |
| US-5380462-A | Cyclohexyl alkenoate compounds | HOFFMANN-LA ROCHE INC. (US) | 1995-01-10 | — | — | US | claimed |
| EP-0047261-B1 | STABILISED COMPOSITIONS CONTAINING BEHAVIOUR MODIFYING COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-06-20 | — | — | EP | claimed |
| US-12043674-B2 | Synthetic cyclic peptides and methods of preparation and use thereof | AUBURN UNIVERSITY (US) | 2024-07-23 | — | — | US | disclosed |
| US-20240239786-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | YALE UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
| CN-113195441-B | Androgen receptor modulators and methods of use thereof | 埃萨制药股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024148308-A1 | NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024148267-A1 | HETEROCYCLIC PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS | EMPATHBIO, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| US-4032647-A | HYPOLIPIDEMIC AGENTS | RICHARDSON-MERRELL INC. (US) | 1977-06-28 | — | — | US | disclosed |
| US-4017514-A | Hypolipidemic agents | RICHARDSON-MERRELL INC. (US) | 1977-04-12 | — | — | US | disclosed |
| US-4013774-A | INSECTICIDAL N-THIO-SUBSTITUTED CARBAMATES OF DIHYDROBENZOFURANOLS | CHEVRON RESEARCH COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-4011334-A | USE OF SUBSTITUTED FURAN AND THIOPHENE CARBOXALDEHYDES AS HYPOLIPIDEMIC AGENTS | RICHARDSON-MERRELL INC. (US) | 1977-03-08 | — | — | US | disclosed |
| US-4011333-A | SUBSTITUTED THIOPHENECARBOXYLIC ACID AND ESTERS AS HYPOLIPIDEMIC AGENTS | RICHARDSON-MERRELL INC. (US) | 1977-03-08 | — | — | US | disclosed |
| US-4000164-A | SUBSTITUTED FUROYLACETIC ACIDS AND ESTERS | RICHARDSON-MERRELL INC. (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043674-B2 | Synthetic cyclic peptides and methods of preparation and use thereof | VIP, PTMS, IAPP | TSHR 2949/4885ABCC4 4760/4885MAPT 4013/4885 |
| US-20240239786-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | BRCA1, RAD51, PARP3 | TSHR 2821/4885ABCC4 1706/4885MAPT 4621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.